Glucosil™

Antimicrobial Resistance Fighting Technology

Research conducted at the Australian Institute of Microbiology and Infection at the University of Technology Sydney, validates the efficacy of Glucosil to kill multi-drug resistant pathogens while minimizing the tendency of bacteria to develop resistance.

• Glucosil penetrates existing biofilm and eradicates them by killing the biofilm forming bacterial threat.

• Glucosil inhibits formation of new biofilms.

• Glucosil kills infectious disease causing bacteria and fungal threats and inactivates viruses listed on the CDC and World health Organization as “Critical Threats”.

• Glucosil has passed safety and toxicity studies as a minimal risk and its safety in human and animal use is supported by numerous scientific studies.